FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfilePolyNovo Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
PNV.AX
PolyNovo Limited Stock AnalysisComprehensive stock analysis for PolyNovo Limited (PNV.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisPNV.AX
PNV.AX
PolyNovo Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
PNV.AX
  1. Home
  2. Stocks
  3. PolyNovo Limited

PolyNovo Limited

🇦🇺PNV.AX•ASX

PolyNovo Limited

🇦🇺PNV.AX•ASX
P/E ratio
79.25

Your view on PNV.AX

P/E
79.25
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About PolyNovo Limited

Industry
Medical - Devices
Sector
Healthcare
CEO
Bruce Peatey
Headquarters
320 Lorimer Street, Port Melbourne, VIC, AU
Industry
Medical - Devices
Sector
Healthcare
CEO
Bruce Peatey
Headquarters
320 Lorimer Street, Port Melbourne, VIC, AU
Description

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong.

The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn.

It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products.

The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for PolyNovo Limited from FRC's valuation model, read against the market price. PNV.AX last traded at AUD 0.88, 79.2× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for PolyNovo Limited. Starting points for PolyNovo Limited: P/E 79.2, EPS AUD 0.01, beta 1.35 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for PolyNovo Limited. PolyNovo Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for PolyNovo Limited. Trailing twelve-month EPS for PolyNovo Limited stands at AUD 0.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · AUD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent QtrJun 2017Next QtrJun 2018Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimate−AUD 0.01−AUD 0.01AUD 0.01AUD 0.02
Low estimate−AUD 0.01−AUD 0.01AUD 0.01AUD 0.02
High estimate−AUD 0.01−AUD 0.01AUD 0.01AUD 0.03
No. of analysts2244
Year-ago EPS——AUD 0.011—
Growth————

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrJun 2017Next QtrJun 2018Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimateAUD 6.09MAUD 7.41MAUD 161.78MAUD 185.70M
Low estimateAUD 5.82MAUD 7.08MAUD 159.70MAUD 181.80M
High estimateAUD 6.12MAUD 7.45MAUD 164.00MAUD 189.50M
No. of analysts2277
Year-ago revenue——AUD 143.71M—
Growth——+12.6%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for PolyNovo Limited. PolyNovo Limited has reported as a listed company since 1998. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold PNV.AX17 companies · 8 funds
Compare PNV.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
ARX.AXAroa Biosurgery LimitedHealthcareMedical - Devices—
CMB.AXCambium Bio LimitedHealthcareBiotechnology—
OCC.AXOrthocell LimitedHealthcareBiotechnology—
OSX.AXOsteopore LimitedHealthcareMedical - Instruments & Supplies—
TRP.AXTissue Repair LtdHealthcareBiotechnology—
TTX.AXTetratherix Ltd.HealthcareBiotechnology—
More Medical - Devices companies
TickerTypeCompanySectorExchangeMkt cap
ARMMArmm Inc.HealthcareOTC$106,246
ASAPFAurora Spine CorporationHealthcareOTC$16.4M
ASG.VAurora Spine CorporationHealthcareTSXV$16.2M
ASTI.CNAquarius Surgical Technologies Inc.HealthcareCNQ—
AT1.AXAtomo Diagnostics LimitedHealthcareASX—
ATECAlphatec Holdings, Inc.HealthcareNASDAQ$1.1B
AVH.AXAVITA Medical, Inc.HealthcareASX—
AVHHLAVITA Medical, Inc.HealthcareOTC$99.4M
AVRAnteris Technologies Global Corp.HealthcareNASDAQ$507.9M
AVR.AXAnteris Technologies LtdHealthcareASX—
AXGNAxoGen, Inc.HealthcareNASDAQ$3.4B
ETFs holding PolyNovo Limited
TickerFundFund assets% of the fund
VXUSVanguard Total International Stock ETF$163.2B in assets0.00%
VEAVanguard FTSE Developed Markets ETF$231.6B in assets0.00%
VSSVanguard FTSE All-World ex-US Small-Cap ETF$11.6B in assets0.01%
SPDWState Street SPDR Portfolio Developed World ex-US ETF$41.0B in assets0.00%
AVDSAvantis International Small Cap Equity ETF$379M in assets0.01%
DFISDimensional - International Small Cap ETF$5.8B in assets0.00%
VIU.TOVanguard FTSE Developed All Cap ex North America Index ETF$11.4B in assets0.00%
VSGXVanguard ESG International Stock ETF$6.7B in assets0.00%

Largest holders first, then the funds most concentrated in PNV.AX.

Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for PolyNovo Limited. Coverage tracks PolyNovo Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of PolyNovo Limited.

PNV.AX AnalysisFair
Past
1
Growth
5
Health
4
Profit
2
Value
1

News

Latest Market News